Ozaki T, Imada C, Shirakami K, Abe T, Shingai Y, Umeki T, Fukuda A, Ishii K, Shibata H.

Serum Soluble Interleukin-2 Receptor as a Potential Marker for Assessing Disease Activity in the TAFRO Subtype of Idiopathic Multicentric Castleman Disease.

Intern Med 2025.doi: 10.2169/internalmedicine.4791-24.

https://pubmed.ncbi.nlm.nih.gov/39924238/